We have previously shown that the PI3K pathway regulates HIF‐2α specifically via mTORC2 and in addition is a promising treatment strategy using a triple PIM/PI3K/mTOR inhibitor in trunk neural crest‐derived tumor form neuroblastoma.27, 28. The gene discussed is MTOR; the disease is neuroblastoma.